// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Is workplace-based assessment (WBA) worthwhile?

Robert Primhak - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

COPD.Pal: Using a person-based approach to develop a self-management app for people with COPD

Liam Knox - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Children’s interstital lung diseases (chILD) – an area of unmet educational need?

Elise Weir - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The effect of COVID-19 on the respiratory workforce and trainee education

Sam Bartlett-Pestell - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Audience response systems aid confidence in managing hospitalised patients with pneumonia online

William Ricketts - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Respiratory upskilling training sessions for redeployed clinical staff in the COVID-19 pandemic

Nicola Smallcombe - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Identification of HuR-specific RNA interactome in TGF-ß1-activated fibroblasts in response to cigarette smoke

Sofia Winslow - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Transcriptome analysis of ciliary differentiation in airway epithelium

Jelmer Legebeke - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Accelerated age-dependent elastin degradation in bronchiectasis

Jeffrey T.-J. Huang - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Evolution of tetracycline resistant S. aureus in hypoxia

Rebecca Hull - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Tetracycline

Inhaled corticosteroids reduce senescence in endothelial progenitor cells from COPD patients

Koralia Paschalaki - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Sulfasalazine

Increasing risk of exacerbation and mortality associated with increasing frequency and severity of exacerbations in COPD patients: EXACOS-UK

Hannah Whittaker - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Predicting 12-month mortality in a Scottish COPD cohort

Shane Burns - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Patient characteristics and invasive ventilation decisions in ECOPD

Sarah M. Gillespie - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Heterogeneity and time course of asthma exacerbations: data from AUSTRI

Helen K Reddel - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Fluticasone propionate

A pictorial asthma action plan to improve asthma control in Malaysian adults

Sazlina Shariff Ghazali - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Small airways dysfunction predicts asthma control and exacerbations: Longitudinal Data from ATLANTIS Study

Monica Kraft - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

SK1211

Adrenal function improvement after oral corticosteroid reduction in benralizumab-treated severe eosinophilic asthma: PONENTE maintenance phase

Mark Gurnell - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Benralizumab

The SF-36 quality of life scales are sensitive measures of lung function decline

Jorunn Kirkeleit - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Eosinophilic phenotype classification of patients with asthma and/or COPD in NOVELTY

David Price - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Copyright © 2026. QuantiNova All rights reserved